NOK 3.19
(-4.61%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.00 USD | 0.0% |
2022 | - USD | -100.0% |
2021 | 1.00 USD | 0.0% |
2020 | 1.00 USD | -50.0% |
2019 | 2.00 NOK | 0.0% |
2018 | - NOK | 0.0% |
2017 | - NOK | 0.0% |
2016 | - NOK | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 FY | 1.00 USD | 0.0% |
2023 Q4 | 1.00 USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q3 | - NOK | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q2 | - NOK | 0.0% |
2022 Q1 | - NOK | 0.0% |
2021 Q4 | - NOK | 0.0% |
2021 Q3 | - NOK | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Arctic Bioscience AS | 32.79 Million NOK | 100.0% |
Aqua Bio Technology ASA | 5.69 Million NOK | 100.0% |
ArcticZymes Technologies ASA | 12.87 Million NOK | 100.0% |
BerGenBio ASA | 7.84 Million NOK | 100.0% |
Hofseth BioCare ASA | 82.54 Million NOK | 100.0% |
PCI Biotech Holding ASA | 1000.00 NOK | 99.9% |
Thor Medical ASA | - NOK | -Infinity% |
Ultimovacs ASA | 1.00 NOK | 0.0% |